JP2018511616A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018511616A5 JP2018511616A5 JP2017553122A JP2017553122A JP2018511616A5 JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5 JP 2017553122 A JP2017553122 A JP 2017553122A JP 2017553122 A JP2017553122 A JP 2017553122A JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- compound according
- unsubstituted
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 28
- 150000001875 compounds Chemical class 0.000 claims 14
- -1 thiocarbamoyl Chemical group 0.000 claims 13
- 229910052757 nitrogen Inorganic materials 0.000 claims 12
- 125000003118 aryl group Chemical group 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 125000002877 alkyl aryl group Chemical group 0.000 claims 10
- 125000004429 atoms Chemical group 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims 6
- 125000004414 alkyl thio group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- FDDDEECHVMSUSB-UHFFFAOYSA-N Sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 229960001663 sulfanilamide Drugs 0.000 claims 3
- 125000006414 CCl Chemical group ClC* 0.000 claims 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000003302 alkenyloxy group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims 2
- 125000005277 alkyl imino group Chemical group 0.000 claims 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000005133 alkynyloxy group Chemical group 0.000 claims 2
- 125000001769 aryl amino group Chemical group 0.000 claims 2
- 125000005418 aryl aryl group Chemical group 0.000 claims 2
- 125000005116 aryl carbamoyl group Chemical group 0.000 claims 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 2
- 125000004467 aryl imino group Chemical group 0.000 claims 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 2
- 125000005163 aryl sulfanyl group Chemical group 0.000 claims 2
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 2
- 125000005110 aryl thio group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 2
- 239000004202 carbamide Substances 0.000 claims 2
- 229960000539 carbamide Drugs 0.000 claims 2
- 235000013877 carbamide Nutrition 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000002579 carboxylato group Chemical group [O-]C(*)=O 0.000 claims 2
- 150000002170 ethers Chemical class 0.000 claims 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 2
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 claims 2
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 claims 2
- 125000001810 isothiocyanato group Chemical group *N=C=S 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims 2
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical group [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 125000000394 phosphonato group Chemical group [O-]P([O-])(*)=O 0.000 claims 2
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 claims 2
- 150000003014 phosphoric acid esters Chemical class 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims 2
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- 150000003577 thiophenes Chemical class 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- 229940093912 Gynecological Sulfonamides Drugs 0.000 claims 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 1
- 241001135917 Vitellaria paradoxa Species 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 125000001651 cyanato group Chemical group [*]OC#N 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229940079867 intestinal antiinfectives Sulfonamides Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940005938 ophthalmologic antiinfectives Sulfonamides Drugs 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- 150000003557 thiazoles Chemical class 0.000 claims 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 1
- 229940026752 topical Sulfonamides Drugs 0.000 claims 1
- 0 *C1=C([N+](*)(*)[O-])OC2=*C(C3=NC=C*3)=I=*C(*)=C12 Chemical compound *C1=C([N+](*)(*)[O-])OC2=*C(C3=NC=C*3)=I=*C(*)=C12 0.000 description 1
Claims (13)
- 式(I)を有する化合物、ならびにその薬学的に許容される塩:
X6はNまたはCRcであり;
R1は、−(CH2)n1CH3(n1=0−7)、
CFyHz(y+z=3)、CClyHz(y+z=3)、OH、OAc、OMe、R71、OR72、CN、N(R73)2、
を含む分枝または直鎖アルキルからなる群より選択され;
R5は、H、OH、Cl、F、NH2、N(R76)2、およびOR77からなる群より選択され;
R6およびR7はそれぞれ独立して、下記の1つとすることができ:
R6がH、非置換チオフェン、または非置換チアゾールであり、およびR1がブチルである場合、R7は、水素ではなく;およびR6がH、または非置換フェニル、チオフェン、またはチアゾールであり、およびR1がベンジルまたは(CH2)n5(CH3)(n5=0−5)である場合、R7は非置換フェニルではない。 - X6はNまたはCHである、請求項1に記載の化合物。
- R6は、5−6個の環原子を含む、置換もしくは非置換ヘテロシクリルである、請求項1〜2のいずれかに記載の化合物。
- R6は置換もしくは非置換チオフェン、チアゾール、オキサゾール、イミダゾール、ピリジン、またはフェニルである、請求項1〜3のいずれかに記載の化合物。
- nが1である、請求項1〜4のいずれかに記載の化合物。
- R7は、H、置換もしくは非置換アリール、置換もしくは非置換シクロアルキル、および置換もしくは非置換ヘテロシクリル、アルキル、またはカルボキシ、例えばカルボン酸(−CO2H)、カルボキシエステル(−CO2アルキル)およびカルボキサミド[−CON(H)(アルキル)または−CO2N(アルキル)2]からなる群より選択される、請求項1〜5のいずれかに記載の化合物。
- 式(III)を有する化合物、ならびにその薬学的に許容される塩:
X6はNまたはCRcであり;
X7はNまたはCであり;
R1は、−(CH2)n1CH3(n1=0−7)、
CFyHz(y+z=3)、CClyHz(y+z=3)、OH、OAc、OMe、R71、OR72、CN、N(R73)2、
を含む分枝または直鎖アルキルからなる群より選択され;
R5は、H、OH、Cl、F、NH2、N(R76)2、およびOR77からなる群より選択され;
R7はそれぞれ独立して、下記の1つとすることができ:
R7は、下記ではない:
- X6はNまたはCHである、請求項8に記載の化合物。
- nは1である、請求項8〜9のいずれかに記載の化合物。
- 医薬組成物の調製における、請求項1〜12のいずれかに記載の化合物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562147305P | 2015-04-14 | 2015-04-14 | |
US62/147,305 | 2015-04-14 | ||
PCT/US2016/027549 WO2016168472A1 (en) | 2015-04-14 | 2016-04-14 | Compositions and methods of modulating short-chain dehydrogenase activity |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018511616A JP2018511616A (ja) | 2018-04-26 |
JP2018511616A5 true JP2018511616A5 (ja) | 2019-05-30 |
Family
ID=57127188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017553122A Pending JP2018511616A (ja) | 2015-04-14 | 2016-04-14 | 短鎖デヒドロゲナーゼ活性を調節する組成物および方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US20180118756A1 (ja) |
EP (1) | EP3283074A4 (ja) |
JP (1) | JP2018511616A (ja) |
CN (1) | CN108012528A (ja) |
AU (1) | AU2016248080A1 (ja) |
CA (1) | CA2982784A1 (ja) |
HK (1) | HK1250651A1 (ja) |
WO (1) | WO2016168472A1 (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9801863B2 (en) | 2012-04-16 | 2017-10-31 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis |
DK2838533T3 (da) | 2012-04-16 | 2017-11-27 | Univ Case Western Reserve | Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet |
US9789116B2 (en) | 2013-10-15 | 2017-10-17 | Case Western Reserve University | Compositions and methods of modulating short-chain dehydrogenase activity |
US10945998B2 (en) | 2015-03-08 | 2021-03-16 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for treating fibrosis |
US20190275014A1 (en) * | 2016-07-18 | 2019-09-12 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting cell death |
US11690847B2 (en) | 2016-11-30 | 2023-07-04 | Case Western Reserve University | Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof |
WO2018145080A1 (en) | 2017-02-06 | 2018-08-09 | Case Western Reserve University | Compositions and methods of modulating short-chain dehydrogenase activity |
JP7178360B2 (ja) * | 2017-04-07 | 2022-11-25 | ケース ウエスタン リザーブ ユニバーシティ | 冠状動脈障害を治療するための短鎖型デヒドロゲナーゼ活性の阻害剤 |
EP3781154A4 (en) * | 2018-04-04 | 2022-02-23 | Case Western Reserve University | COMPOSITIONS AND METHODS FOR TREATING KIDNEY DAMAGE |
MX2021005982A (es) | 2018-11-21 | 2021-09-23 | Univ Case Western Reserve | Composiciones y metodos para modular la actividad de deshidrogenasas de cadena corta. |
CN114206337A (zh) * | 2019-06-11 | 2022-03-18 | 莱兰斯坦福初级大学评议会 | 通过抑制15-羟基前列腺素脱氢酶(15-pgdh)使老化组织复壮的方法 |
MX2022010258A (es) * | 2020-02-21 | 2023-01-24 | Univ Case Western Reserve | Composiciones y métodos para tratar la lesión renal. |
AU2021275122A1 (en) | 2020-05-20 | 2022-12-15 | Board Of Regents Of The University Of Texas System | Compositions and methods of modulating short-chain dehydrogenase activity |
EP4232026A1 (en) * | 2020-10-23 | 2023-08-30 | The Board of Trustees of the Leland Stanford Junior University | Elevation of mitochondrial biogenesis and function by inhibition of prostaglandin degrading enzyme 15-pgdh |
AU2021396543A1 (en) * | 2020-12-09 | 2023-07-06 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of prostaglandin degrading enzyme 15-pgdh to improve joint structure and function |
WO2023143432A1 (zh) * | 2022-01-28 | 2023-08-03 | 赛诺哈勃药业(成都)有限公司 | 一种调控15-pgdh活性的化合物及其制备方法 |
TW202346303A (zh) * | 2022-04-13 | 2023-12-01 | 大陸商賽諾哈勃藥業(成都)有限公司 | 一種調控15-pgdh活性的化合物、包含其的藥物組合物及其用途 |
WO2024099429A1 (zh) * | 2022-11-11 | 2024-05-16 | 赛诺哈勃药业(成都)有限公司 | 一种调控15-pgdh活性的化合物及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4904672A (en) * | 1987-01-30 | 1990-02-27 | Merck & Co., Inc. | Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors |
US6281227B1 (en) * | 1996-12-13 | 2001-08-28 | Aventis Pharma Deutschland Gmbh | Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
DE60216823T2 (de) * | 2001-03-30 | 2007-10-04 | Pfizer Products Inc., Groton | Zwischenprodukten für die Herstellung von Pyridazinon Aldose Reductase Inhibitoren. |
AU2003257145B2 (en) * | 2002-08-02 | 2008-11-13 | Merck Sharp & Dohme Corp. | Substituted furo (2,3-b) pyridine derivatives |
MX2007000762A (es) * | 2004-07-22 | 2007-04-02 | Ptc Therapeutics Inc | Tienopiridinas para tratamientode hepatitis c. |
TW200801012A (en) * | 2006-04-26 | 2008-01-01 | Piramed Ltd | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
US20100093764A1 (en) * | 2008-10-13 | 2010-04-15 | Devraj Chakravarty | AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
WO2010077101A2 (ko) * | 2008-12-30 | 2010-07-08 | 조선대학교산학협력단 | 신규한 티아졸리딘디온 유도체 및 그의 용도 |
DK2838533T3 (da) * | 2012-04-16 | 2017-11-27 | Univ Case Western Reserve | Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet |
US9801863B2 (en) * | 2012-04-16 | 2017-10-31 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis |
US9789116B2 (en) * | 2013-10-15 | 2017-10-17 | Case Western Reserve University | Compositions and methods of modulating short-chain dehydrogenase activity |
US10945998B2 (en) * | 2015-03-08 | 2021-03-16 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for treating fibrosis |
JP2019078488A (ja) * | 2017-10-25 | 2019-05-23 | ダイキン工業株式会社 | 空気調和装置 |
-
2016
- 2016-04-14 CA CA2982784A patent/CA2982784A1/en not_active Abandoned
- 2016-04-14 CN CN201680034932.5A patent/CN108012528A/zh active Pending
- 2016-04-14 JP JP2017553122A patent/JP2018511616A/ja active Pending
- 2016-04-14 US US15/566,637 patent/US20180118756A1/en not_active Abandoned
- 2016-04-14 AU AU2016248080A patent/AU2016248080A1/en not_active Abandoned
- 2016-04-14 EP EP16780752.8A patent/EP3283074A4/en not_active Withdrawn
- 2016-04-14 WO PCT/US2016/027549 patent/WO2016168472A1/en unknown
-
2018
- 2018-08-08 HK HK18110182.7A patent/HK1250651A1/zh unknown
-
2020
- 2020-05-08 US US16/869,879 patent/US20210094968A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018511616A5 (ja) | ||
JP2020514323A5 (ja) | ||
AR059009A1 (es) | 2 - (poli - arilo sustituido) - 6 - amino - 5 - halo - 4 - acidos pirimidinacarboxilico, su uso como herbicida en composiciones que lo contienen y en metodos para controlar la vegetacion no deseada. | |
WO2006098918B1 (en) | Substituted gamma lactams as therapeutic agents | |
JP2009535307A5 (ja) | ||
WO2008042240A3 (en) | Enantiomerically pure phosphoindoles as hiv inhibitors | |
JP2004175807A5 (ja) | ||
WO2009013299A3 (de) | Neue bradykinin b1-antagonisten | |
JP2008044952A5 (ja) | ||
MX2009009492A (es) | Compuestos organicos biciclicos adecuados para el tratamiento de condiciones inflamatorias o alergicas. | |
SG169339A1 (en) | Aryl sulfonamides with an analgesic action | |
JP2011513431A5 (ja) | ||
RU2010139644A (ru) | Ингибитор фиброза | |
AR048306A1 (es) | Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40 | |
EP2207062A3 (en) | Photosensitive compositions, curable compositions, novel compounds, photopolymerizable compositions, color filters, and planographic printing plate precursors | |
WO2007032028A8 (en) | Thiazolinones and oxazolinones and their use as ptp1b inhibitors | |
HRP20070577T4 (hr) | Derivati kinazolinona koji se mogu upotrijebiti kao antagonisti vaniloida | |
JP2018530582A5 (ja) | ||
JP2010511626A5 (ja) | ||
EA200800502A1 (ru) | Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения | |
RU2013139313A (ru) | 6-амино-2-замещенные-5- винилсилилпиримидин-4-карбоновые кислоты и сложные эфиры и 4-амино-6-замещенные-3-винилсилилпиридин-пиколиновые кислоты и сложные эфиры как гербициды | |
JP2013517322A5 (ja) | ||
WO2009013348A3 (en) | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions | |
RU2008129641A (ru) | Ингибиторы ccr9 активности | |
WO2011089529A4 (en) | Salicylate fatty acid derivatives |